What is the function of triglycerides and how are high levels managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Triglyceride Function and Management of High Levels

Triglycerides are essential energy storage molecules in the body, but elevated levels require lifestyle modifications as first-line treatment, followed by pharmacological intervention for severe cases to reduce cardiovascular risk and prevent pancreatitis. 1

Physiological Function of Triglycerides

  • Triglycerides make up the majority of dietary fat consumed in industrialized nations and serve as the body's primary mechanism for efficient energy storage 1, 2
  • They play a crucial role in energy metabolism, serving as a concentrated source of calories that can be stored in adipose tissue and mobilized during periods of energy need 1
  • When properly regulated, triglycerides are part of normal lipid metabolism, but dysregulation leads to hypertriglyceridemia with associated health risks 3

Classification of Triglyceride Levels

  • The American Heart Association classifies triglyceride levels as:
    • Normal: <150 mg/dL
    • Borderline high: 150-199 mg/dL
    • High: 200-499 mg/dL
    • Very high: ≥500 mg/dL 4
  • Optimal fasting triglyceride levels for cardiovascular health are considered to be <100 mg/dL 4, 5

Health Implications of Elevated Triglycerides

  • Elevated triglycerides are associated with:
    • Increased risk of atherosclerotic cardiovascular disease (ASCVD) 5, 6
    • Visceral adiposity and insulin resistance 4
    • Type 2 diabetes mellitus 4, 2
    • Nonalcoholic hepatic steatosis (fatty liver) 4
  • Very high triglyceride levels (≥500 mg/dL) increase risk for pancreatitis, while moderate elevations (200-499 mg/dL) are more associated with atherosclerotic risk 5
  • Hypertriglyceridemia alters lipoprotein metabolism by increasing remnant cholesterol particles, which are causally linked to atherosclerosis 5, 3

Management of Elevated Triglycerides

Assessment for Secondary Causes

  • Evaluate for secondary causes of hypertriglyceridemia:
    • Uncontrolled diabetes 4, 7
    • Alcohol consumption 4, 7
    • Medications (corticosteroids, estrogens, antipsychotics, antiretrovirals) 4
    • Hypothyroidism 2
    • Family history of dyslipidemia 4

Lifestyle Modifications (First-Line Treatment)

  • Weight loss: A 5-10% reduction in body weight can lower triglycerides by approximately 20% 4, 7
  • Dietary changes:
    • Reduce carbohydrate intake, especially added sugars and fructose 4, 5
    • Eliminate dietary trans fatty acids 4
    • Increase omega-3 fatty acid consumption 4
    • Moderate fat intake with emphasis on unsaturated fats 4
    • For severe hypertriglyceridemia (≥1000 mg/dL), implement extreme dietary fat restriction (<5% of total calories as fat) 7
  • Physical activity: Aim for at least 150 minutes per week of moderate-intensity aerobic activity 4, 7
  • Complete elimination of alcohol consumption, especially for those with severe hypertriglyceridemia 7

Pharmacological Treatment

  • For high triglyceride levels (200-499 mg/dL):
    • The treatment goal is a non-HDL cholesterol level 30 mg/dL higher than the LDL goal 4
    • Statins are typically used as part of overall lipid management strategy 8, 9
  • For severe hypertriglyceridemia (≥500 mg/dL):
    • Fibrates are the first-line treatment for triglycerides ≥1500 mg/dL 7, 9
    • Fenofibrate is indicated as adjunctive therapy to diet for treatment of adult patients with severe hypertriglyceridemia 9
    • Consider adding prescription omega-3 fatty acids if response to fibrate is inadequate 7
    • Avoid statins as monotherapy for severe hypertriglyceridemia (≥1500 mg/dL), as they are not effective as first-line treatment for this condition 7

Important Considerations and Caveats

  • Despite the use of statin therapy, ASCVD event rates remain high in patients with elevated triglycerides, suggesting they represent a marker of residual cardiovascular risk 5, 10
  • While triglyceride levels serve as a biomarker for cardiovascular risk, there is insufficient evidence that lowering triglyceride levels alone improves cardiovascular outcomes beyond LDL-C and non-HDL-C targets 4
  • Fenofibrate at a dose equivalent to 160 mg was not shown to reduce coronary heart disease morbidity and mortality in a large, randomized controlled trial of patients with type 2 diabetes mellitus 9
  • Markedly elevated levels of serum triglycerides (e.g., > 2,000 mg/dL) may increase the risk of developing pancreatitis, but the effect of fenofibrate therapy on reducing this risk has not been adequately studied 9
  • Patients with impaired renal function should start with lower doses of fenofibrate (54 mg per day), and the medication should be avoided in patients with severe renal impairment 9

References

Research

New approaches to triglyceride reduction: Is there any hope left?

American journal of preventive cardiology, 2024

Research

The triglyceride issue: a view from Framingham.

American heart journal, 1986

Research

Hypertriglyceridaemia and risk of coronary artery disease.

Nature reviews. Cardiology, 2017

Guideline

Triglyceride Management and Cardiovascular Risk

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Elevated Triglycerides and Cardiovascular Disease Risk

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Triglycerides and risk for coronary artery disease.

Current atherosclerosis reports, 2008

Guideline

Management of Severe Hypertriglyceridemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.